SCHEMBL5692483

SCHEMBL5692483

O=C(O)c1cc(=O)[nH]c(=S)[nH]1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 3/20 1.00
ALDH1A1 P00352 3/20 0.63
LMNA P02545 1/20 0.63
BAZ2B Q9UIF8 1/20 0.54
SMN1; SMN2 Q16637 3/20 0.52
ALOX15 P16050 1/20 0.52
NFKB1 P19838 1/20 0.52
BLM P54132 1/20 0.52
LPO P22079 2/20 0.48
PTGS1 P23219 1/20 0.48
TAS2R38 P59533 2/20 0.46
TSHR P16473 2/20 0.41
SIRT2 Q8IXJ6 1/20 0.41
SIRT1 Q96EB6 1/20 0.41
MPO P05164 1/20 0.41
TPO P07202 1/20 0.41
MAPT P10636 2/20 0.40
GPR35 Q9HC97 3/20 0.39
GRIN2D O15399 2/20 0.39
GRIN3B O60391 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5692504 0.82 CYP2C19 (0.68) CYP2C19ALDH1A1LMNASMN1; SMN2ALOX15
SCHEMBL3072588 0.80 CYP2C19 (0.67) CYP2C19ALDH1A1LMNASMN1; SMN2ALOX15
Orotic Acid SCHEMBL29394966 0.77 ALDH1A1 (1.00) CYP2C19ALDH1A1LMNASMN1; SMN2ALOX15
Orotic Acid SCHEMBL431534 0.77 ALDH1A1 (1.00) CYP2C19ALDH1A1LMNASMN1; SMN2ALOX15
Orotic Acid SCHEMBL20865 0.77 ALDH1A1 (1.00) CYP2C19ALDH1A1LMNASMN1; SMN2ALOX15
SCHEMBL12872719 0.76 CYP1A2 (0.68) CYP2C19ALDH1A1LMNABAZ2BSMN1; SMN2
Orotic Acid SCHEMBL23859825 0.76 ALDH1A1 (0.95) CYP2C19ALDH1A1LMNASMN1; SMN2ALOX15
Orotic Acid SCHEMBL122311 0.76 ALDH1A1 (0.95) CYP2C19ALDH1A1LMNASMN1; SMN2ALOX15
Orotic Acid SCHEMBL896844 0.76 ALDH1A1 (0.95) CYP2C19ALDH1A1LMNASMN1; SMN2ALOX15
Orotic Acid SCHEMBL1005001 0.76 ALDH1A1 (0.95) CYP2C19ALDH1A1LMNASMN1; SMN2ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110452387-B Polysiloxane capable of being cured by ultraviolet light and preparation method and application thereof 广东工业大学 2021-06-15 CN disclosed
EP-1644338-A1 2, 4, 6-TRISUBSTITUTED PYRIMIDINE DERIVATIVES USEFUL FOR THE TREATMENT OF NEOPLASTIC AND AUTOIMMUNE DISEASES Aponetics AG (CH) 2006-04-12 EP disclosed
WO-2004087679-A1 2, 4, 6-TRISUBSTITUTED PYRIMIDINE DERIVATIVES USEFUL FOR THE TREATMENT OF NEOPLASTIC AND AUTOIMMUNE DISEASES APONETICS AG (CH) 2004-10-14 WO disclosed
EP-0802194-B1 Novel thiouracil derivatives and metal surface-treating agent comprising thereof TOKUYAMA CORP (JP) 2002-06-19 EP disclosed
EP-1091958-A1 SALTS OF PAROXETINE SMITHKLINE BEECHAM PLC (GB) 2001-04-18 EP disclosed
WO-2000001692-A1 SALTS OF PAROXETINE SMITHKLINE BEECHAM PLC (GB) 2000-01-13 WO disclosed
US-5795497-A Thiouracil derivatives and metal surface-treating agent comprising thereof TOKUYAMA CORPORATION (JP) 1998-08-18 US disclosed
EP-0802194-A2 Novel thiouracil derivatives and metal surface-treating agent comprising thereof TOKUYAMA CORPORATION (JP) 1997-10-22 EP disclosed
US-4113950-A PROCESS FOR PREPARING OROTIC ACID AND THIOOROTIC ACID DIAMALT AKTIENGESELLSCHAFT (DE) 1978-09-12 US disclosed
US-4062847-A Process for preparing orotic acid DIAMALT AKTIENGESELLSCHAFT (DT) 1977-12-13 US disclosed